Join us at these upcoming national events:
Centers for Disease Control National Conference on Community Health Assessment
August 18-20, 2008
Atlanta, GA
Using the Clinical Laboratory for Public Health Surveillance of Chronic Disease
Panelists from national and local public health agencies and industry will present their experiences and plans for using clinical laboratory data to enhance the public health surveillance of chronic diseases, with special emphasis on diabetes. Issues will include choice of laboratory tests; technical challenges to data collection; strengths and limitations of the data; analysis and presentation methods; use of the data for public health planning and policy, research, and patient care patient confidentiality; ethical, legal and social issues costs of implementation; and, future directions for laboratory based surveillance.
Learning Objectives:
- Understand the strengths and limitations of clinical laboratory data for public health surveillance of diabetes
- Understand the technical, ethical, legal and social barriers to using clinical laboratory data
- Discuss methods to improve and spread the use of this technique to other settings
Panelists:
Shadi Chamany, MD, MPH (or designee)
Director of Diabetes Prevention and Control, New York City Department of Health and Mental Hygiene
"Progress and Pitfalls in Implementing a Mandatory A1C Registry"
Edward Gregg, PhD
Chief, Epidemiology and Statistics Branch, Division of Diabetes Translation, CDC
"Incorporating Laboratory Data into the National Diabetes Surveillance System"
Fernando Guerra, MD, MPH
Director of the San Antonio Metropolitan District Health Department
"San Antonio's Approach to Laboratory-Based Surveillance"
Benjamin Littenberg, MD
University of Vermont and Vermont Clinical Decision Support, LLC
"Ethical, Legal, Social and Technical Challenges to Laboratory-Based Surveillance"
Charles MacLean, MDCM
University of Vermont and Vermont Clinical Decision Support, LLC
"Using a Laboratory Based Registry to Improve Outcomes in Diabetes"
Jones Seminars on Science, Technology, and Society, Thayer School of Engineering at Dartmouth College
May 16, 2008
Automated Use of Clinical Laboratory Results in Adults
Diabetes mellitus is a major and growing source of disability and death in America and across the world. It is highly disruptive to patients, their families, employers and communities and responsible for huge expenses to individuals, insurers, governments and charities. Advances in the management have led to the possibility of controlling the altered physiology of diabetes and preventing the long-term complications that are the source of so much distress. However, optimum management is complicated and difficult for both providers and patients and has been difficult to achieve in most settings. The Vermedx Diabetes Information System accepts clinical laboratory results and uses them in novel ways to support the provider and patient in better adhering to management plans for diabetes. This presentation will describe the design criteria for the system, the system architecture employed, the products generated, and the results of a large scale clinical trial. It will also discuss the use of the resulting database for public health surveillance of diabetes at a population level.
Podcasts of the Jones Seminar series are available here.
CDC's Division of Diabetes Translation Annual Conference
May 5-8, 2008
Wyndham Orlando Resort, 8001 International Drive, Orlando, Florida.
Session: A Lab-based Diabetes Registry Approach for Population Assessment and Management
Session: Chronic Disease Registries in Public Health
The CDC’s Division of Diabetes Translation will convene its annual Diabetes Conference May 5–8, 2008, at the Wyndham Orlando Resort Hotel, 8001 International Drive, Orlando, Florida. The conference will bring together more than 600 participants from a wide range of local, state, federal, and territorial governmental agencies and private-sector diabetes partners.
Conference Goals
Explore science, policy, education, program planning, implementation, and evaluation to enhance public health approaches and strategies to prevent and control diabetes. Increase knowledge and awareness of successful, cost-effective, public and private diabetes programs. Present innovative strategies to increase awareness of diabetes and how to prevent its complications. Provide opportunities for skill-building, information-sharing, and networking.